<--- Back to Details
First PageDocument Content
Pharmaceutics / European Federation of Pharmaceutical Industries and Associations / Risk management / European Medicines Agency / Good manufacturing practice / Good Automated Manufacturing Practice / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology
Date: 2015-01-20 07:15:59
Pharmaceutics
European Federation of Pharmaceutical Industries and Associations
Risk management
European Medicines Agency
Good manufacturing practice
Good Automated Manufacturing Practice
Pharmaceutical industry
Pharmaceutical sciences
Pharmacology

Microsoft Word[removed]Interrupted Supply - Inter-Association Summary-final report.doc

Add to Reading List

Source URL: www.efpia.eu

Download Document from Source Website

File Size: 866,87 KB

Share Document on Facebook

Similar Documents

Press Release EBiSC – the first European bank for induced pluripotent stem cells Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces wi

DocID: 1tXAK - View Document

Health care / Health / Medical research / Pharmaceutical industry / Clinical research / European Federation of Pharmaceutical Industries and Associations / Conflict of interest / Medical privacy / Privacy / Clinical trial

EFPIA Disclosure Code: Your Questions Answered March 2016 #pharmadisclosure www.efpia.eu

DocID: 1rsSj - View Document

Biotechnology / Economy / European Federation of Biotechnology / Science and technology / Technology / Meeting / European Federation of Pharmaceutical Industries and Associations / British Science Association / Medicon Valley

European Federation of Biotechnology Microbial Physiology Section The 2007 Annual meeting of the EFB Microbial Physiology Section was held aton Monday 17th September during ECB13, Fira de Barcelona in Barcelona,

DocID: 1rnG2 - View Document

Pharmaceutical sciences / Pharmacology / Business / Pharmaceutical industry / Pharmacy / Biotechnology / European Federation of Pharmaceutical Industries and Associations / Immunogenicity / Drug discovery / Novartis / Biopharmaceutical / Sanofi

ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

DocID: 1rlyu - View Document

European Federation of Pharmaceutical Industries and Associations / Health / Business / HCPS

About the EFPIA Disclosure Code Securing the future of collaboration between industry and healthcare professionals Collaboration between industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) be

DocID: 1rkGi - View Document